Scott Oehrlein
Plus aucun poste en cours
Profil
Scott Oehrlein is an Independent Director at Sauvie, Inc. He was previously the Chief Operating Officer at VIVUS, Inc. from 2018 to 2019.
Prior to that, he was the Head-Primary Care Sales US at Novartis Pharmaceuticals Corp.
from 2012 to 2014 and the Vice President & Head-General Medicines Sales at Sanofi Corp.
from 2014 to 2017.
He also served as the Global Chief Operations Officer at Willow Biopharma, Inc. from 2017 to 2018.
Oehrlein received his undergraduate degree from Franklin & Marshall College.
Postes actifs de Scott Oehrlein
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Scott Oehrlein
| Sociétés | Poste | Fin |
|---|---|---|
| VIVUS, INC. | Chief Operating Officer | 31/10/2019 |
Willow Biopharma, Inc.
 Willow Biopharma, Inc. Medical/Nursing ServicesHealth Services Willow Biopharma, Inc. engages in the development of biopharmaceutical products. It offers medicine to cure cancer, cardiovascular disease, metabolic disorders, digestive disorders, and dermatologic conditions. The company was founded by Kenneth Suh and is headquartered in Markham, Canada. | Chief Operating Officer | 01/04/2018 |
| Sanofi Corp. | Corporate Officer/Principal | 01/06/2017 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/04/2014 |
Formation de Scott Oehrlein
| Franklin & Marshall College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| Sanofi Corp. | |
Willow Biopharma, Inc.
Willow Biopharma, Inc. Medical/Nursing ServicesHealth Services Willow Biopharma, Inc. engages in the development of biopharmaceutical products. It offers medicine to cure cancer, cardiovascular disease, metabolic disorders, digestive disorders, and dermatologic conditions. The company was founded by Kenneth Suh and is headquartered in Markham, Canada. | Health Services |
